-
Expensive Rare Disease Therapies Questioned by Advocacy Groups, Doctors
Therapies for rare disease are becoming increasingly expensive, and patient advocacy groups, doctors and pharmaceutical executives have some concerns. Click here to read about what different stakeholders in the rare disease community have to say about the rising costs of treatments.
What are your thoughts on this news?
-
0 Replies
Sorry, there were no replies found.
Log in to reply.